Promomed Group participated in the Second Russia–Africa Summit in St. Petersburg

For the second year in a row, the Russia–Africa summit has gathered leaders and representatives of almost all African states at its site in St. Petersburg. The event is primarily aimed at building a mutually beneficial partnership and strengthening cooperation between Russia and African countries in all its areas, including pharmaceuticals.

Two conferences were organized within the framework of the summit, where experts from different countries were able to discuss the most important issues related to the course towards consolidating joint efforts between Russia and Africa in the field of healthcare and drug policy development, which will be able to form a sustainable trend of mutually beneficial partnership.

Promomed Group of Companies was represented at the summit by Sergey Koida, Director of Export Sales. Sergey has successfully negotiated with many potential partners, including from Tanzania, Uganda, Mali and other countries.

"Africa is a continent with a population of 1.5 billion people. This is both a large market in terms of sales, and there are a huge number of patients that we can help by providing high-quality products for treatment. It is no secret that in African countries there is a great need for cancer and HIV therapy. These nosologies are a priority at Promomed, and we are actively developing portfolios of antiviral and oncological drugs, so we can offer patients effective modern drug therapy," said Sergey Koida.

Promomed Group's strategic plans include a large–scale entry into foreign markets. In particular, along with the Middle East and Asian countries, the African direction is also being considered. In May of this year, a delegation from the Republic of Cameroon visited the Biochemist plant on a working visit, following which partnership agreements were reached.